Scott A. Armstrong, M.D., Ph.D., of the Dana-Farber Cancer Institute, studies how certain aggressive forms of acute myeloid leukemia (AML) develop and survive. His work centers on a protein called menin, which helps leukemia cells keep cancer-promoting genes switched on. Armstrong’s team has found that blocking menin with specially designed drugs can shut down these gene programs, push leukemia cells to mature, and slow or stop the disease in lab models and patients. While some leukemias adapt by developing mutations in menin or finding other ways to survive, his research is revealing why certain genes are especially dependent on menin and how to target them more effectively. These discoveries are now shaping new treatments, drug combinations, and potential strategies for other cancers that rely on similar mechanisms. Series: "Stem Cell Channel" [Health and Medicine] [Science] [Show ID: 40875]
No persons identified in this episode.
This episode hasn't been transcribed yet
Help us prioritize this episode for transcription by upvoting it.
Popular episodes get transcribed faster
Other recent transcribed episodes
Transcribed and ready to explore now
3ª PARTE | 17 DIC 2025 | EL PARTIDAZO DE COPE
01 Jan 1970
El Partidazo de COPE
12:00H | 21 DIC 2025 | Fin de Semana
01 Jan 1970
Fin de Semana
#158 - Szilágyi Tamás: A húszas éveid arra valók, hogy legalább egyszer becsődölj
21 Dec 2025
Mindenségit!
Tödliche Ernte
21 Dec 2025
Schattenakte - Der Fall der Woche
Origines de Stars : Shai Gilgeous Alexander ! (Calendrier Avent #21)
21 Dec 2025
Le Basket Lab (NBA Podcast)
The BEST XI in the 2025 West Indies Championship
21 Dec 2025
Caribbean Cricket Podcast